Skip to main content
Erschienen in: European Radiology 9/2022

31.03.2022 | Breast

Can DWI provide additional value to Kaiser score in evaluation of breast lesions

verfasst von: Yongyu An, Guoqun Mao, Weiqun Ao, Fan Mao, Hongxia Zhang, Yougen Cheng, Guangzhao Yang

Erschienen in: European Radiology | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore added value of diffusion-weighted imaging (DWI) as an adjunct to Kaiser score (KS) for differentiation of benign from malignant lesions on breast magnetic resonance imaging (MRI).

Methods

Two hundred forty-six patients with 273 lesions (155 malignancies) were included in this retrospective study from January 2015 to December 2019. All lesions were proved by pathology. Two radiologists blind to pathological results evaluated lesions according to KS. Lesions with score > 4 were considered malignant. Four thresholds of ADC values −1.3 × 10−3mm2/s, 1.4 × 10−3mm2/s, 1.53 × 10−3mm2/s, and 1.6 × 10−3mm2/s were used to distinguish benign from malignant lesions. For combined diagnosis, a lesion with KS > 4 and ADC values below the preset cutoffs was considered as malignant; otherwise, it was benign. Sensitivity, specificity, and area under the curve (AUC) were compared between KS, DWI, and combined diagnosis.

Results

The AUC of KS was significantly higher than that of DWI alone (0.941 vs 0.901, p = 0.04). The sensitivity of KS (96.8%) and DWI (97.4 – 99.4%) was comparable (p > 0.05) while the specificity of KS (83.9%) was significantly higher than that of DWI (19.5–56.8%) (p < 0.05). Adding DWI as an adjunct to KS resulted in a 0–2.5% increase of specificity and a 0.1–1.3% decrease of sensitivity; however, the difference did not reach statistical significance (p > 0.05).

Conclusion

KS showed higher diagnostic performance than DWI alone for discrimination of breast benign and malignant lesions. DWI showed no additional value to KS for characterizing breast lesions.

Key Points

• KS showed higher diagnostic performance than DWI alone for differentiation of benign from breast malignant lesions.
• DWI alone showed a high sensitivity but a low specificity for characterizing breast lesions.
• Diagnostic performance did not improve using DWI as an adjunct to KS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424PubMedCrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424PubMedCrossRef
2.
Zurück zum Zitat Bennani-Baiti B, Bennani-Baiti N, Baltzer PA (2016) Diagnostic performance of breast magnetic resonance imaging in non-calcified equivocal breast findings: results from a systematic review and meta-analysis. PLoS One 11:e160346 Bennani-Baiti B, Bennani-Baiti N, Baltzer PA (2016) Diagnostic performance of breast magnetic resonance imaging in non-calcified equivocal breast findings: results from a systematic review and meta-analysis. PLoS One 11:e160346
4.
Zurück zum Zitat Kim SJ, Morris EA, Liberman L et al (2001) Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses. AJR Am J Roentgenol 177:551–557PubMedCrossRef Kim SJ, Morris EA, Liberman L et al (2001) Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses. AJR Am J Roentgenol 177:551–557PubMedCrossRef
5.
Zurück zum Zitat Grimm LJ, Anderson AL, Baker JA et al (2015) Interobserver variability between breast imagers using the fifth edition of the BI-RADS MRI lexicon. AJR Am J Roentgenol 204:1120–1124PubMedCrossRef Grimm LJ, Anderson AL, Baker JA et al (2015) Interobserver variability between breast imagers using the fifth edition of the BI-RADS MRI lexicon. AJR Am J Roentgenol 204:1120–1124PubMedCrossRef
6.
Zurück zum Zitat Baltzer PA, Kaiser WA, Dietzel M (2015) Lesion type and reader experience affect the diagnostic accuracy of breast MRI: a multiple reader ROC study. Eur J Radiol 84:86–91PubMedCrossRef Baltzer PA, Kaiser WA, Dietzel M (2015) Lesion type and reader experience affect the diagnostic accuracy of breast MRI: a multiple reader ROC study. Eur J Radiol 84:86–91PubMedCrossRef
7.
Zurück zum Zitat Baltzer PA, Dietzel M, Kaiser WA (2013) A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol 23:2051–2060PubMedCrossRef Baltzer PA, Dietzel M, Kaiser WA (2013) A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol 23:2051–2060PubMedCrossRef
8.
Zurück zum Zitat Marino MA, Clauser P, Woitek R et al (2016) A simple scoring system for breast MRI interpretation: does it compensate for reader experience? Eur Radiol 26:2529–2537PubMedCrossRef Marino MA, Clauser P, Woitek R et al (2016) A simple scoring system for breast MRI interpretation: does it compensate for reader experience? Eur Radiol 26:2529–2537PubMedCrossRef
9.
Zurück zum Zitat Woitek R, Spick C, Schernthaner M et al (2017) A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions. Eur Radiol 27:3799–3809PubMedPubMedCentralCrossRef Woitek R, Spick C, Schernthaner M et al (2017) A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions. Eur Radiol 27:3799–3809PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Milos RI, Pipan F, Kalovidouri A et al (2020) The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams. Eur Radiol 30:6052–6061PubMedPubMedCentralCrossRef Milos RI, Pipan F, Kalovidouri A et al (2020) The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams. Eur Radiol 30:6052–6061PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Wengert GJ, Pipan F, Almohanna J et al (2020) Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI. Eur Radiol 30:1451–1459PubMedCrossRef Wengert GJ, Pipan F, Almohanna J et al (2020) Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI. Eur Radiol 30:1451–1459PubMedCrossRef
12.
Zurück zum Zitat Dietzel M, Krug B, Clauser P et al (2021) A multicentric comparison of apparent diffusion coefficient mapping and the Kaiser Score in the assessment of breast lesions. Invest Radiol 56:274–282PubMedCrossRef Dietzel M, Krug B, Clauser P et al (2021) A multicentric comparison of apparent diffusion coefficient mapping and the Kaiser Score in the assessment of breast lesions. Invest Radiol 56:274–282PubMedCrossRef
13.
Zurück zum Zitat Dorrius MD, Dijkstra H, Oudkerk M, Sijens PE (2014) Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis. Eur Radiol 24:2835–2847PubMedCrossRef Dorrius MD, Dijkstra H, Oudkerk M, Sijens PE (2014) Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis. Eur Radiol 24:2835–2847PubMedCrossRef
14.
Zurück zum Zitat Min Q, Shao K, Zhai L et al (2015) Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging. World J Surg Oncol 13:32PubMedPubMedCentralCrossRef Min Q, Shao K, Zhai L et al (2015) Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging. World J Surg Oncol 13:32PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Baxter GC, Graves MJ, Gilbert FJ, Patterson AJ (2019) A meta-analysis of the diagnostic performance of diffusion MRI for breast lesion characterization. Radiology 291:632–641PubMedCrossRef Baxter GC, Graves MJ, Gilbert FJ, Patterson AJ (2019) A meta-analysis of the diagnostic performance of diffusion MRI for breast lesion characterization. Radiology 291:632–641PubMedCrossRef
16.
Zurück zum Zitat Shi RY, Yao QY, Wu LM, Xu JR (2018) Breast Lesions: diagnosis using diffusion weighted imaging at 1.5T and 3.0T-systematic review and meta-analysis. Clin Breast Cancer 18:e305–e320PubMedCrossRef Shi RY, Yao QY, Wu LM, Xu JR (2018) Breast Lesions: diagnosis using diffusion weighted imaging at 1.5T and 3.0T-systematic review and meta-analysis. Clin Breast Cancer 18:e305–e320PubMedCrossRef
17.
Zurück zum Zitat Spick C, Pinker-Domenig K, Rudas M, Helbich TH, Baltzer PA (2014) MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol 24:1204–1210PubMedCrossRef Spick C, Pinker-Domenig K, Rudas M, Helbich TH, Baltzer PA (2014) MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol 24:1204–1210PubMedCrossRef
18.
Zurück zum Zitat Dijkstra H, Dorrius MD, Wielema M, Pijnappel RM, Oudkerk M, Sijens PE (2016) Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions. J Magn Reson Imaging 44:1642–1649PubMedCrossRef Dijkstra H, Dorrius MD, Wielema M, Pijnappel RM, Oudkerk M, Sijens PE (2016) Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions. J Magn Reson Imaging 44:1642–1649PubMedCrossRef
19.
Zurück zum Zitat Pinker K, Moy L, Sutton EJ et al (2018) Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter: comparison with dynamic contrast-enhanced and multiparametric magnetic resonance imaging. Invest Radiol 53:587–595PubMedPubMedCentralCrossRef Pinker K, Moy L, Sutton EJ et al (2018) Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter: comparison with dynamic contrast-enhanced and multiparametric magnetic resonance imaging. Invest Radiol 53:587–595PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Rahbar H, Zhang Z, Chenevert TL et al (2019) Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN Cancer Research Group (A6702). Clin Cancer Res 25:1756–1765PubMedPubMedCentralCrossRef Rahbar H, Zhang Z, Chenevert TL et al (2019) Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN Cancer Research Group (A6702). Clin Cancer Res 25:1756–1765PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Dietzel M, Baltzer P (2018) How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay. Insights Imaging 9:325–335PubMedPubMedCentralCrossRef Dietzel M, Baltzer P (2018) How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay. Insights Imaging 9:325–335PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Arponen O, Sudah M, Masarwah A et al (2015) Diffusion-weighted imaging in 3.0 Tesla breast MRI: diagnostic performance and tumor characterization using small subregions vs. whole tumor regions of interest. PLoS One 10:e138702 Arponen O, Sudah M, Masarwah A et al (2015) Diffusion-weighted imaging in 3.0 Tesla breast MRI: diagnostic performance and tumor characterization using small subregions vs. whole tumor regions of interest. PLoS One 10:e138702
23.
Zurück zum Zitat Zhang M, Horvat JV, Bernard-Davila B et al (2019) Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy. J Magn Reson Imaging 49:864–874PubMedCrossRef Zhang M, Horvat JV, Bernard-Davila B et al (2019) Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy. J Magn Reson Imaging 49:864–874PubMedCrossRef
24.
Zurück zum Zitat Wielema M, Dorrius MD, Pijnappel RM et al (2020) Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: a systematic review and meta-analysis. PLoS One 15:e232856 Wielema M, Dorrius MD, Pijnappel RM et al (2020) Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: a systematic review and meta-analysis. PLoS One 15:e232856
25.
Zurück zum Zitat Bickel H, Pinker K, Polanec S et al (2017) Diffusion-weighted imaging of breast lesions: region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol 27:1883–1892PubMedCrossRef Bickel H, Pinker K, Polanec S et al (2017) Diffusion-weighted imaging of breast lesions: region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol 27:1883–1892PubMedCrossRef
26.
Zurück zum Zitat Baltzer P, Mann RM, Iima M et al (2020) Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 30:1436–1450PubMedCrossRef Baltzer P, Mann RM, Iima M et al (2020) Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 30:1436–1450PubMedCrossRef
27.
Zurück zum Zitat Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI. Eur Radiol 31:356–336l Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI. Eur Radiol 31:356–336l
28.
Zurück zum Zitat Baltzer A, Dietzel M, Kaiser CG, Baltzer PA (2016) Combined reading of contrast enhanced and diffusion weighted magnetic resonance imaging by using a simple sum score. Eur Radiol 26:884–891PubMedCrossRef Baltzer A, Dietzel M, Kaiser CG, Baltzer PA (2016) Combined reading of contrast enhanced and diffusion weighted magnetic resonance imaging by using a simple sum score. Eur Radiol 26:884–891PubMedCrossRef
29.
Zurück zum Zitat Woodhams R, Matsunaga K, Kan S et al (2005) ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4:35–42PubMedCrossRef Woodhams R, Matsunaga K, Kan S et al (2005) ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4:35–42PubMedCrossRef
30.
Zurück zum Zitat Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD (2009) BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol 193:994–1000PubMedCrossRef Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD (2009) BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol 193:994–1000PubMedCrossRef
31.
Zurück zum Zitat Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA (2010) False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol 194:1658–1663PubMedCrossRef Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA (2010) False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol 194:1658–1663PubMedCrossRef
32.
Zurück zum Zitat Ma W, Guo X, Liu L et al (2020) Magnetic resonance imaging semantic and quantitative features analyses: an additional diagnostic tool for breast phyllodes tumors. Am J Transl Res 12:2083–2092PubMedPubMedCentral Ma W, Guo X, Liu L et al (2020) Magnetic resonance imaging semantic and quantitative features analyses: an additional diagnostic tool for breast phyllodes tumors. Am J Transl Res 12:2083–2092PubMedPubMedCentral
33.
Zurück zum Zitat Avendano D, Marino MA, Leithner D et al (2019) Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI. Breast Cancer Res 21:136PubMedPubMedCentralCrossRef Avendano D, Marino MA, Leithner D et al (2019) Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI. Breast Cancer Res 21:136PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Kul S, Eyuboglu I, Cansu A, Alhan E (2014) Diagnostic efficacy of the diffusion weighted imaging in the characterization of different types of breast lesions. J Magn Reson Imaging 40:1158–1164PubMedCrossRef Kul S, Eyuboglu I, Cansu A, Alhan E (2014) Diagnostic efficacy of the diffusion weighted imaging in the characterization of different types of breast lesions. J Magn Reson Imaging 40:1158–1164PubMedCrossRef
35.
Zurück zum Zitat Zhang L, Tang M, Min Z, Lu J, Lei X, Zhang X (2016) Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis. Acta Radiol 57:651–660PubMedCrossRef Zhang L, Tang M, Min Z, Lu J, Lei X, Zhang X (2016) Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis. Acta Radiol 57:651–660PubMedCrossRef
36.
Zurück zum Zitat Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A (2011) Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 196:210–217PubMedCrossRef Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A (2011) Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 196:210–217PubMedCrossRef
37.
Zurück zum Zitat Baltzer P, Bickel H, Spick C et al (2018) Potential of noncontrast magnetic resonance imaging with diffusion-weighted imaging in characterization of breast lesions: intraindividual comparison with dynamic contrast-enhanced magnetic resonance imaging. Invest Radiol 53:229–235PubMedPubMedCentralCrossRef Baltzer P, Bickel H, Spick C et al (2018) Potential of noncontrast magnetic resonance imaging with diffusion-weighted imaging in characterization of breast lesions: intraindividual comparison with dynamic contrast-enhanced magnetic resonance imaging. Invest Radiol 53:229–235PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Belli P, Bufi E, Bonatesta A et al (2016) Unenhanced breast magnetic resonance imaging: detection of breast cancer. Eur Rev Med Pharmacol Sci 20:4220–4229PubMed Belli P, Bufi E, Bonatesta A et al (2016) Unenhanced breast magnetic resonance imaging: detection of breast cancer. Eur Rev Med Pharmacol Sci 20:4220–4229PubMed
39.
Zurück zum Zitat Bickelhaupt S, Tesdorff J, Laun FB et al (2017) Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings. Eur Radiol 27:562–569PubMedCrossRef Bickelhaupt S, Tesdorff J, Laun FB et al (2017) Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings. Eur Radiol 27:562–569PubMedCrossRef
40.
Zurück zum Zitat Shin HJ, Chae EY, Choi WJ et al (2016) Diagnostic performance of fused diffusion-weighted imaging using unenhanced or postcontrast T1-weighted MR imaging in patients with breast cancer. Medicine (Baltimore) 95:e3502CrossRef Shin HJ, Chae EY, Choi WJ et al (2016) Diagnostic performance of fused diffusion-weighted imaging using unenhanced or postcontrast T1-weighted MR imaging in patients with breast cancer. Medicine (Baltimore) 95:e3502CrossRef
41.
Zurück zum Zitat Liberman L, Morris EA, Lee MJ et al (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179:171–178PubMedCrossRef Liberman L, Morris EA, Lee MJ et al (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179:171–178PubMedCrossRef
42.
Zurück zum Zitat Fujiwara K, Yamada T, Kanemaki Y et al (2018) Grading system to categorize breast MRI in BI-RADS 5th Edition: a multivariate study of breast mass descriptors in terms of probability of malignancy. AJR Am J Roentgenol 210:W118–W127PubMedCrossRef Fujiwara K, Yamada T, Kanemaki Y et al (2018) Grading system to categorize breast MRI in BI-RADS 5th Edition: a multivariate study of breast mass descriptors in terms of probability of malignancy. AJR Am J Roentgenol 210:W118–W127PubMedCrossRef
43.
Zurück zum Zitat Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS (2015) Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol 22:1157–1162PubMedCrossRef Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS (2015) Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol 22:1157–1162PubMedCrossRef
44.
Zurück zum Zitat Petrillo A, Fusco R, Sansone M et al (2017) Abbreviated breast dynamic contrast-enhanced MR imaging for lesion detection and characterization: the experience of an Italian oncologic center. Breast Cancer Res Treat 164:401–410PubMedCrossRef Petrillo A, Fusco R, Sansone M et al (2017) Abbreviated breast dynamic contrast-enhanced MR imaging for lesion detection and characterization: the experience of an Italian oncologic center. Breast Cancer Res Treat 164:401–410PubMedCrossRef
45.
Zurück zum Zitat Dietzel M, Ellmann S, Schulz-Wendtland R et al (2020) Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves? Eur Radiol 30:47–56PubMedCrossRef Dietzel M, Ellmann S, Schulz-Wendtland R et al (2020) Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves? Eur Radiol 30:47–56PubMedCrossRef
46.
Zurück zum Zitat Yang X, Dong M, Li S et al (2020) Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions. Eur Radiol 30:4795–4805PubMedCrossRef Yang X, Dong M, Li S et al (2020) Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions. Eur Radiol 30:4795–4805PubMedCrossRef
Metadaten
Titel
Can DWI provide additional value to Kaiser score in evaluation of breast lesions
verfasst von
Yongyu An
Guoqun Mao
Weiqun Ao
Fan Mao
Hongxia Zhang
Yougen Cheng
Guangzhao Yang
Publikationsdatum
31.03.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 9/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08674-x

Weitere Artikel der Ausgabe 9/2022

European Radiology 9/2022 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.